CAS No. 417716-92-8
| IUPAC Name | 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide | |
|---|---|---|
| CAS Number | 417716-92-8 | |
| Molecular Formula |
C21H19ClN4O4 |
|
| Molecular Weight (MW) | 426.85 | |
| SMILES | COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl | |
| InChIKey | WOSKHXYHFSIKNG-UHFFFAOYSA-N |
Lenvatinib (E7080) is a potent multi-target kinase inhibitor primarily targeting VEGFR2 (IC50 = and VEGFR3 (IC50 = 5.2 nM), while also inhibiting VEGFR1, FGFR1-4, PDGFR, KIT, and RET. By suppressing receptor tyrosine kinase autophosphorylation and downstream VEGF signaling pathways, it potently impairs vascular endothelial cell proliferation and tube formation. Consequently, lenvatinib inhibits angiogenesis and lymphangiogenesis, resulting in marked suppression of tumor growth and metastasis. [1]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
20 mg/mL
(46.85 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
50 mg/mL
(117.13 mM)
; Warmed with 60°C water bath
; Ultrasonicated
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
17 mg/mL
(39.82 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
40 mg/mL
(93.7 mM)
; Warmed with 60°C water bath
; Ultrasonicated
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
40 mg/mL
(93.7 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- E7080 (Lenvatinib) Mechanism of Action: VEGFR Inhibition in Endothelial Cells Research
- E7080 (Lenvatinib) Clinical Trials
- E7080 (Lenvatinib): Selectivity & Specificity
- E7080 (Lenvatinib) Working Concentration | Cell Culture | Treatment
- E7080 (Lenvatinib) Solubility in DMSO
- E7080 (Lenvatinib) Stock Solution
- E7080 (Lenvatinib) Storage
- E7080 (Lenvatinib) Stability
- E7080 (Lenvatinib) Combination Database
- E7080 (Lenvatinib) Molecular Weight
- E7080 (Lenvatinib) SMILES
- E7080 (Lenvatinib) Chemical Structure (2D and 3D)
- E7080 (Lenvatinib) IC50 for Cell-based and Cell-free Assays
- E7080 (Lenvatinib) Sigma (SML3017)? Try a better option.
- E7080 (Lenvatinib) MedChemExpress (HY-10981)? Try a better option.
- E7080 (Lenvatinib) Cayman (19375)? Try a better option.
- E7080 (Lenvatinib) Abmole (M1841)? Try a better option.
- E7080 (Lenvatinib) SDS|MSDS